Adaptimmune Therapeutics PLC Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptimmune Therapeutics PLC for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Sell | S | 5.67 | 2,111 | 11,968 | 3,539 | 5.7 K to 3.5 K (-37.36 %) |
| Jan 19 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 5.67 | 4,358 | 24,708 | 7,346 | 11.7 K to 7.3 K (-37.24 %) |
| Jan 19 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.67 | 9,879 | 56,009 | 13,529 | 23.4 K to 13.5 K (-42.20 %) |
| Jan 12 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 6.15 | 2,234 | 13,744 | 3,768 | 6 K to 3.8 K (-37.22 %) |
| Jan 12 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 6.15 | 1,058 | 6,509 | 1,767 | 2.8 K to 1.8 K (-37.45 %) |
| Jan 12 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Sell | S | 6.15 | 841 | 5,174 | 1,396 | 2.2 K to 1.4 K (-37.59 %) |
| Jan 12 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 6.15 | 2,707 | 16,654 | 3,695 | 6.4 K to 3.7 K (-42.28 %) |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Wood Gavin | Chief Financial Off ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Wood Gavin | Chief Financial Off ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.00 | 728,160 | 1,019 | 728,160 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 1.03 | 3,260,400 | 3,358,212 | 3,260,400 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | TAYTON-MARTIN HELEN KATRINA | Chief Business Offi ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | TAYTON-MARTIN HELEN KATRINA | Chief Business Offi ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
| Jan 05 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 5.33 | 1,065 | 5,674 | 1,760 | 2.8 K to 1.8 K (-37.70 %) |
| Jan 05 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 5.33 | 3,499 | 18,642 | 5,864 | 9.4 K to 5.9 K (-37.37 %) |
| Jan 05 2021 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Sell | S | 5.33 | 845 | 4,502 | 1,392 | 2.2 K to 1.4 K (-37.77 %) |
| Jan 05 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.33 | 4,967 | 26,464 | 6,737 | 11.7 K to 6.7 K (-42.44 %) |